103892-77-9

Basic information

• Product Name: [(S)-5-Amino-6-(4-benzyl-piperidin-1-yl)-6-oxo-hexyl]-carbamic acid benzyl ester; hydrochloride
• CAS NO: 103892-77-9
• Molecular Weight: 474.043
• Mol File: 103892-77-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: [(S)-5-Amino-6-(4-benzyl-piperidin-1-yl)-6-oxo-hexyl]-carbamic acid benzyl ester; hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: [(S)-5-Amino-6-(4-benzyl-piperidin-1-yl)-6-oxo-hexyl]-carbamic acid benzyl ester; hydrochloride(103892-77-9)
• EPA Substance Registry System: [(S)-5-Amino-6-(4-benzyl-piperidin-1-yl)-6-oxo-hexyl]-carbamic acid benzyl ester; hydrochloride(103892-77-9)

Safety Data

• Hazardous Substances Data: 103892-77-9(Hazardous Substances Data)

Upstream product

• 2389-45-9 Boc-Lys(Z)-OH 
• 31252-42-3 4-benzylpyperidine 
• 103892-76-8 [(S)-6-(4-Benzyl-piperidin-1-yl)-5-tert-butoxycarbonylamino-6-oxo-hexyl]-carbamic acid benzyl ester 

Downstream Products

• 103880-79-1 N^α-trans-4-aminomethylcyclohexanecarbonyllysine 4-benzylpiperidine amide 
• 116194-02-6 2-Amino-3-methyl-pentanoic acid {(S)-1-[(S)-5-amino-1-(4-benzyl-piperidine-1-carbonyl)-pentylcarbamoyl]-2-phenyl-ethyl}-amide 
• 116194-19-5 {(S)-6-(4-Benzyl-piperidin-1-yl)-5-[(S)-2-((S)-2-tert-butoxycarbonylamino-3-methyl-pentanoylamino)-3-phenyl-propionylamino]-6-oxo-hexyl}-carbamic acid benzyl ester 
• 116194-19-5 {(S)-6-(4-Benzyl-piperidin-1-yl)-5-[(S)-2-(2-tert-butoxycarbonylamino-3-methyl-pentanoylamino)-3-phenyl-propionylamino]-6-oxo-hexyl}-carbamic acid benzyl ester 
• 116227-14-6 [(S)-5-((S)-2-Amino-3-phenyl-propionylamino)-6-(4-benzyl-piperidin-1-yl)-6-oxo-hexyl]-carbamic acid benzyl ester; hydrochloride 
• 116194-18-4 {(S)-6-(4-Benzyl-piperidin-1-yl)-5-[(S)-2-(3-methyl-pentanoylamino)-3-phenyl-propionylamino]-6-oxo-hexyl}-carbamic acid benzyl ester 
• 116194-00-4 (S)-N-[(S)-5-Amino-1-(4-benzyl-piperidine-1-carbonyl)-pentyl]-3-phenyl-2-(toluene-4-sulfonylamino)-propionamide 
• 138848-85-8 [(S)-5-{[4-(Benzyloxycarbonylamino-methyl)-cyclohexanecarbonyl]-amino}-6-(4-benzyl-piperidin-1-yl)-6-oxo-hexyl]-carbamic acid benzyl ester 

Relevant articles and documents

Development of active center-directed inhibitors against plasmin

Active center-directed inhibitors of plasmin were designed based on the structure of specific substrates of plasmin and then synthesized. Their effects on plasmin were examined and the structure-inhibitory activity relationship was studied. N(α)-trans-4-A